Short-Term Cocaine Treatment Causes Neuroadaptive Changes in Gαq and Gα11 Proteins in Rats Undergoing Withdrawal
One of the characteristics of drug dependence is that a drug has to be administered repeatedly before withdrawal effects can be observed. We have previously shown that withdrawal after 14 days of cocaine treatment produces a supersensitivity of hypothalamic 5-hydroxytryptamine (serotonin) 2A (5-HT 2...
Saved in:
Published in | The Journal of pharmacology and experimental therapeutics Vol. 311; no. 1; p. 349 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
American Society for Pharmacology and Experimental Therapeutics
01.10.2004
|
Online Access | Get full text |
Cover
Loading…
Abstract | One of the characteristics of drug dependence is that a drug has to be administered repeatedly before withdrawal effects can
be observed. We have previously shown that withdrawal after 14 days of cocaine treatment produces a supersensitivity of hypothalamic
5-hydroxytryptamine (serotonin) 2A (5-HT 2A ) receptors, which is accompanied by increases in the levels of Gα q and Gα 11 proteins. Unfortunately, the exact duration of cocaine treatment necessary to induce alterations in G protein levels during
cocaine withdrawal is unknown. The present study investigated the minimum cocaine treatment period required to produce changes
in protein levels of membrane- and cytosol-associated Gα q and Gα 11 proteins in the hypothalamic paraventricular nucleus, amygdala, and frontal cortex. Rats were injected with cocaine (15 mg/kg
i.p., b.i.d.) for 0, 1, 3, 5, and 7 days and tested after 2 days of withdrawal. The levels of Gα q and Gα 11 proteins were increased in the paraventricular nucleus and the amygdala but not in the frontal cortex. Although 1 and 3 days
of cocaine treatment were sufficient to maximally elevate the protein levels of Gα 11 and Gα q proteins in the amygdala, 5 days of treatment were required to maximally increase the levels of Gα 11 and Gα q proteins in the paraventricular nucleus. The data suggest that the amygdala shows a faster neuroadaptation to the effects
of cocaine than the hypothalamic paraventricular nucleus. These findings provide insight into the relative importance of individual
components of 5-HT 2A receptor signal transduction system in regulating the overall sensitivity of this signaling in cocaine-treated rats. |
---|---|
AbstractList | One of the characteristics of drug dependence is that a drug has to be administered repeatedly before withdrawal effects can
be observed. We have previously shown that withdrawal after 14 days of cocaine treatment produces a supersensitivity of hypothalamic
5-hydroxytryptamine (serotonin) 2A (5-HT 2A ) receptors, which is accompanied by increases in the levels of Gα q and Gα 11 proteins. Unfortunately, the exact duration of cocaine treatment necessary to induce alterations in G protein levels during
cocaine withdrawal is unknown. The present study investigated the minimum cocaine treatment period required to produce changes
in protein levels of membrane- and cytosol-associated Gα q and Gα 11 proteins in the hypothalamic paraventricular nucleus, amygdala, and frontal cortex. Rats were injected with cocaine (15 mg/kg
i.p., b.i.d.) for 0, 1, 3, 5, and 7 days and tested after 2 days of withdrawal. The levels of Gα q and Gα 11 proteins were increased in the paraventricular nucleus and the amygdala but not in the frontal cortex. Although 1 and 3 days
of cocaine treatment were sufficient to maximally elevate the protein levels of Gα 11 and Gα q proteins in the amygdala, 5 days of treatment were required to maximally increase the levels of Gα 11 and Gα q proteins in the paraventricular nucleus. The data suggest that the amygdala shows a faster neuroadaptation to the effects
of cocaine than the hypothalamic paraventricular nucleus. These findings provide insight into the relative importance of individual
components of 5-HT 2A receptor signal transduction system in regulating the overall sensitivity of this signaling in cocaine-treated rats. |
Author | Nancy A. Muma Louis D. Van de Kar Francisca Garcia Katerina J. Damjanoska George Battaglia Deborah N. D'Souza Gonzalo A. Carrasco Yahong Zhang |
Author_xml | – sequence: 1 fullname: Gonzalo A. Carrasco – sequence: 2 fullname: Katerina J. Damjanoska – sequence: 3 fullname: Deborah N. D'Souza – sequence: 4 fullname: Yahong Zhang – sequence: 5 fullname: Francisca Garcia – sequence: 6 fullname: George Battaglia – sequence: 7 fullname: Nancy A. Muma – sequence: 8 fullname: Louis D. Van de Kar |
BookMark | eNqNikFOwzAQRS1URFNgzdYrdkk9sZPSdQR0hVAJYhmNmiF2ldjBdltxCe7CFeBiIOAArP7Te3_GJtZZYuwCRAaQq_l2pJiBUJkol1diccQSKHJIBQg5YYkQeZ7KoiymbBbCVghQqpQnbAoFLAqVy4TtH7TzMa3JD7xyGzSWeO0J40A28gp3gQK_o5132OIYzZ54pdF239ZYfvv59vH-wtG2vwjA772LZOxPXmMM_NG25DtnbMefTNStxwP2Z-z4GftA5397yi5vrutqlWrT6YPx1Iwa_YAb17vutZEADTRSLeW_j19_S1u_ |
ContentType | Journal Article |
DOI | 10.1124/jpet.104.069807 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1521-0103 |
ExternalDocumentID | 311_1_349 |
GroupedDBID | - 08R 0R 2WC 3O- 4.4 53G 55 5GY 5RE 8RP AALRV ABFLS ABIVO ABOCM ABSGY ABZEH ACDCL ACGFS ACNCT ADACO ADBIT ADCOW ADKFC AENEX AETEA AFFNX AIKQT ALMA_UNASSIGNED_HOLDINGS CS3 DIK DL DU5 E3Z EBS EJD F5P FH7 GJ GX1 H13 HZ INIJC KQ8 L7B LSO O0- O9- OHT OK1 P2P R.V R0Z RHF RHI RPT W2D WH7 WOQ X X7M ZGI ZXP |
ID | FETCH-highwire_pharmacology_311_1_3493 |
ISSN | 0022-3565 |
IngestDate | Tue Jan 05 21:16:48 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-highwire_pharmacology_311_1_3493 |
PMID | 15175423 |
ParticipantIDs | highwire_pharmacology_311_1_349 |
ProviderPackageCode | RHF RHI |
PublicationCentury | 2000 |
PublicationDate | 20041001 |
PublicationDateYYYYMMDD | 2004-10-01 |
PublicationDate_xml | – month: 10 year: 2004 text: 20041001 day: 01 |
PublicationDecade | 2000 |
PublicationTitle | The Journal of pharmacology and experimental therapeutics |
PublicationYear | 2004 |
Publisher | American Society for Pharmacology and Experimental Therapeutics |
Publisher_xml | – name: American Society for Pharmacology and Experimental Therapeutics |
SSID | ssj0014463 |
Score | 3.5702155 |
Snippet | One of the characteristics of drug dependence is that a drug has to be administered repeatedly before withdrawal effects can
be observed. We have previously... |
SourceID | highwire |
SourceType | Publisher |
StartPage | 349 |
Title | Short-Term Cocaine Treatment Causes Neuroadaptive Changes in Gαq and Gα11 Proteins in Rats Undergoing Withdrawal |
URI | http://jpet.aspetjournals.org/content/311/1/349.abstract |
Volume | 311 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa28cIL4iru-IH2gS4htybp41aVTnuYEAuiPFVu4q4bLOnSBER_xP7L_sL4Y5xju45bkAa8JJETJbbPdy6xz4WQ11GUec407VohqGcrCMOJNen5ocXjiHFQB6GTCgfZo_DgY3A46o62tt8YXkt1NbHT5R_jSv6HqtAGdMUo2X-grH4pNMA10BeOQGE4_hWNj2dgPFsJCFfg65ShwZhox_E-qxccpVhdFixjc-EjJIMJhA_sEPfI40Gr77X23QuxibDW5LoYRYDFMMXjH1iFvjQZL08KXF74dFrNspJ9V308a1Bn2LjzJjG2zPO0VlDAiP3Slv2wyJfsa9HZs9EXpWSLtNA6gWFe6Zx1Dm0A6_kZy4vFF61VlODsHMHNlhcdF_VS3_vMZlhSSSyOry1zBNphrjIiC1DkGc6s7zcHMTAHkWwOwgxfkAUqbK6kvodrKo5vqgVfKQET_1LI-zLJ6u_KxwtQ-cDfDu6c207Yi2VFXwOK83OBRbCzsPSw32jhlefBhnLWLpPQnbE7hk9vk1seCFWU5sORdmfC33pfZ8aH4ak0VtCntxs9EpWo5OeNrNiGVZXcJXcUVOiexPY9ssXz-6StZvzHLjVnd5e2qUmLB-RbwwBUMQDVDEAlA9A1BqCKAehpToc_L6-vLihQVF66Ll0BHm8j4GkDeNoA_iFpvxsk_QNrNaqxifOxnkP_EdnJi5w_JjTNsh5z0pjz2AlSlsVBN55GcHKCaDoN2BPy6oaXPb3xiWfkdgPp52SnKmv-AmzZavJSEPEXM4erGA |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Short-Term+Cocaine+Treatment+Causes+Neuroadaptive+Changes+in+G%C3%8E%C2%B1q+and+G%C3%8E%C2%B111+Proteins+in+Rats+Undergoing+Withdrawal&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=Gonzalo+A.+Carrasco&rft.au=Katerina+J.+Damjanoska&rft.au=Deborah+N.+D%27Souza&rft.au=Yahong+Zhang&rft.date=2004-10-01&rft.pub=American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0022-3565&rft.eissn=1521-0103&rft.volume=311&rft.issue=1&rft.spage=349&rft_id=info:doi/10.1124%2Fjpet.104.069807&rft_id=info%3Apmid%2F15175423&rft.externalDBID=n%2Fa&rft.externalDocID=311_1_349 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon |